FDA Clears New Methylphenidate Formulation for ADHD | AIHCP Magazine, Articles & Discussions | Scoop.it
Cotempla XR-ODT is a once-daily extended-release orally disintegrating tablet formulation of methylphenidate for patients aged 6 to 17 years with ADHD.